全文获取类型
收费全文 | 10922篇 |
免费 | 890篇 |
国内免费 | 218篇 |
专业分类
12030篇 |
出版年
2023年 | 244篇 |
2022年 | 302篇 |
2021年 | 446篇 |
2020年 | 427篇 |
2019年 | 586篇 |
2018年 | 540篇 |
2017年 | 411篇 |
2016年 | 409篇 |
2015年 | 410篇 |
2014年 | 872篇 |
2013年 | 1147篇 |
2012年 | 621篇 |
2011年 | 713篇 |
2010年 | 546篇 |
2009年 | 474篇 |
2008年 | 526篇 |
2007年 | 484篇 |
2006年 | 372篇 |
2005年 | 324篇 |
2004年 | 248篇 |
2003年 | 165篇 |
2002年 | 135篇 |
2001年 | 78篇 |
2000年 | 63篇 |
1999年 | 82篇 |
1998年 | 88篇 |
1997年 | 72篇 |
1996年 | 53篇 |
1995年 | 53篇 |
1994年 | 47篇 |
1993年 | 50篇 |
1992年 | 47篇 |
1991年 | 42篇 |
1990年 | 30篇 |
1989年 | 23篇 |
1988年 | 33篇 |
1987年 | 22篇 |
1985年 | 129篇 |
1984年 | 125篇 |
1983年 | 73篇 |
1982年 | 82篇 |
1981年 | 73篇 |
1980年 | 70篇 |
1979年 | 55篇 |
1978年 | 46篇 |
1977年 | 38篇 |
1976年 | 26篇 |
1975年 | 23篇 |
1974年 | 35篇 |
1973年 | 24篇 |
排序方式: 共有10000条查询结果,搜索用时 7 毫秒
41.
42.
43.
Laura
iburc Marius Bembea Dana Carmen Zaha Alexandru Daniel Jurca Cosmin Mihai Vesa Ioana Adela Raiu Claudia Maria Jurca 《Current issues in molecular biology》2022,44(5):1851
IL-17 inhibitors (IL-17i) are medicines used to treat dermatological and rheumatic diseases They belong to a class of medicines called biological disease-modifying anti-rheumatic drugs (bDMARDs). This class of drugs has had a major impact on the therapy of autoimmune diseases, being much safer and more effective than treatment with small molecules. At the same time, they have highly beneficial effects on skin and joint changes, and their efficacy has been extensively monitored and demonstrated in numerous clinical trials. More and more such drugs are still being discovered today to ensure the best possible treatment of these patients, but more frequently and relatively constantly three agents are used. Two of them (Secukinumab and Ixekizumab) inhibit IL-17A directly, and the third, Brodamulab, inhibits the IL-17A receptor. Although they are extremely effective in the treatment of these diseases, sometimes their administration has been associated with paradoxical effects, i.e., there is an exacerbation of the inflammatory process. Tough, clinical trials of IL-17i have described cases of exacerbation or even onset of inflammatory bowel disease (IBD), such as Crohn’s disease and ulcerative colitis, after administration of these drugs in patients previously diagnosed with psoriasis (PS), psoriatic arthritis (PsA), or ankylosing spondylitis (AS). The pathophysiological mechanism of action is not well understood at present. One explanation would be that this hyperreactive inflammatory process would be triggered by Interferon 1 derived from dendritic plasma cells. Even though there are many reports in the recent literature about the role of IL17i in the onset of IBD, conclusions of studies do not converge. Some of them show an increased incidence of IBD in patients treated with IL17i, while some others affirm their safety of them. In the near future we will surely have more data emerging from ongoing meta-analyses regarding safety of use IL17i in patients who are at risk of developing IBD. Clinical and paraclinical evaluation (inflammatory intestinal markers) are carefully advised before recommending treatment with IL-17i and after initiation of treatment, and prospective surveillance by clinical and biomarkers of patients treated with IL-17i is absolutely essential to capture the onset of IBD. 相似文献
44.
Alain Dejean Arthur Compin Maurice Leponce Frédéric Azémar Camille Bonhomme Stanislas Talaga Laurent Pelozuelo Yann Hénaut Bruno Corbara 《Comptes rendus biologies》2018,341(3):200-207
In an inundated Mexican forest, 89 out of 92 myrmecophytic tank bromeliads (Aechmea bracteata) housed an associated ant colony: 13 sheltered Azteca serica, 43 Dolichoderus bispinosus, and 33 Neoponera villosa. Ant presence has a positive impact on the diversity of the aquatic macroinvertebrate communities (n = 30 bromeliads studied). A Principal Component Analysis (PCA) showed that the presence and the species of ant are not correlated to bromeliad size, quantity of water, number of wells, filtered organic matter or incident radiation. The PCA and a generalized linear model showed that the presence of Azteca serica differed from the presence of the other two ant species or no ants in its effects on the aquatic invertebrate community (more predators). Therefore, both ant presence and species of ant affect the composition of the aquatic macroinvertebrate communities in the tanks of A. bracteata, likely due to ant deposition of feces and other waste in these tanks. 相似文献
45.
46.
Colcemid treatment of myeloma prior to cell fusion increases the yield of hybridomas between myeloma and splenocyte 总被引:1,自引:0,他引:1
M Miyahara H Nakamura Y Hamaguchi 《Biochemical and biophysical research communications》1984,124(3):903-908
Effect of Colcemid treatment of myeloma (X63-Ag8-6.5.3.) prior to fusion with mouse spleen cell was studied in terms of hybridoma formation. Spleen cells from BALB/c mice immunized with various soluble antigens were fused with the myeloma cells by using polyethylene glycol solution. Colcemid treatment of myeloma cells prior to fusion increased the average number of hybridoma colonies per well by 26-570%. The yield of hybridomas producing antigen-specific antibodies was also higher with the Colcemid treatment. The results suggest that most of the proliferative hybridomas are formed by fusion of cells in the M-phase of the cell cycle. 相似文献
47.
48.
49.
Peter S. Thuy-Boun Ana Y. Wang Ana Crissien-Martinez Janice H. Xu Sandip Chatterjee Gregory S. Stupp Andrew I. Su Walter J. Coyle Dennis W. Wolan 《Molecular & cellular proteomics : MCP》2022,21(3):100197
The gut microbiota plays an important yet incompletely understood role in the induction and propagation of ulcerative colitis (UC). Organism-level efforts to identify UC-associated microbes have revealed the importance of community structure, but less is known about the molecular effectors of disease. We performed 16S rRNA gene sequencing in parallel with label-free data-dependent LC-MS/MS proteomics to characterize the stool microbiomes of healthy (n = 8) and UC (n = 10) patients. Comparisons of taxonomic composition between techniques revealed major differences in community structure partially attributable to the additional detection of host, fungal, viral, and food peptides by metaproteomics. Differential expression analysis of metaproteomic data identified 176 significantly enriched protein groups between healthy and UC patients. Gene ontology analysis revealed several enriched functions with serine-type endopeptidase activity overrepresented in UC patients. Using a biotinylated fluorophosphonate probe and streptavidin-based enrichment, we show that serine endopeptidases are active in patient fecal samples and that additional putative serine hydrolases are detectable by this approach compared with unenriched profiling. Finally, as metaproteomic databases expand, they are expected to asymptotically approach completeness. Using ComPIL and de novo peptide sequencing, we estimate the size of the probable peptide space unidentified (“dark peptidome”) by our large database approach to establish a rough benchmark for database sufficiency. Despite high variability inherent in patient samples, our analysis yielded a catalog of differentially enriched proteins between healthy and UC fecal proteomes. This catalog provides a clinically relevant jumping-off point for further molecular-level studies aimed at identifying the microbial underpinnings of UC. 相似文献
50.
Woo HN Baik SH Park JS Gwon AR Yang S Yun YK Jo DG 《Biochemical and biophysical research communications》2011,(1):402-15
Accumulation of amyloid-β (Aβ) is widely accepted as the key instigator of Alzheimer’s disease (AD). The proposed mechanism is that accumulation of Aβ results in inflammatory responses, oxidative damages, neurofibrillary tangles and, subsequently, neuronal/synaptic dysfunction and neuronal loss. Given the critical role of Aβ in the disease process, the proteases that produce this peptide are obvious targets. The goal would be to develop drugs that can inhibit the activity of these targets. Protease inhibitors have proved very effective for treating other disorders such as AIDS and hypertension. Mutations in APP (amyloid-β precursor protein), which flanks the Aβ sequence, cause early-onset familial AD, and evidence has pointed to the APP-to-Aβ conversion as a possible therapeutic target. Therapies aimed at modifying Aβ-related processes aim higher up the cascade and are therefore more likely to be able to alter the progression of the disease. However, it is not yet fully known whether the increases in Aβ levels are merely a result of earlier events that were already causing the disease. 相似文献